PTGS2 and hepatocellular carcinoma: COX-2 inhibitors can block these mechanisms by various pathways and selective COX-2 inhibitors have been evaluated for their effect on HCC cell growth and invasion using animal models of hepatocarcinogenesis [9], [10].